ArticleHealthcare (Basel, Switzerland)2022

Evaluating Post-Market Adverse Events of The New Hepatitis C Therapies Using FEARS Data.

Majed A AlgarniPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.